Clinical Pharmacology of Alemtuzumab, an Anti ‐CD52 Immunomodulator, in Multiple Sclerosis

Clinical&Experimental Immunology,Volume 0, Issue ja, -Not available-.

Source: Clinical and Experimental Immunology - August 24, 2018 Category: Allergy & Immunology Authors: Zhaoyang Li , Susan Richards , Howard K. Surks , Alan Jacobs , Michael A. Panzara Source Type: research